ArticleMolecular cancer research : MCR2024

EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent Manner.

Lily L Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.